RNA Therapy May Help Preserve Muscle During GLP-1 Weight Loss
A new Northwestern University study offers a potential solution to muscle loss during GLP-1 therapy: an experimental RNA therapy that induces the body to burn calories, enhancing the benefits of the weight-loss treatment.
Genetic Toolkit May Improve Study of Gut Bacteria’s Role in Disease
A novel genetic toolkit may improve the study of how Clostridia bacteria in the gut contribute to disease and reveal new molecular mechanisms that may serve as effective therapeutic targets, as detailed in a recent study published in Nature Biotechnology.
Experimental Drug Shows Potential for Hard-to-Treat Heart Disease
An experimental drug has been shown to improve symptoms, exercise capacity and heart failure status in patients with an inherited heart disease, according to a pair of newly published studies.